Financial Ratios

ADD-LIFE PHARMA LTD.

NSE : NABSE : 524665ISIN CODE : INE124C01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.460 (0 %)
PREV CLOSE ( ) 0.46
OPEN PRICE ( ) 0.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.50 0.50
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2005Mar2004Mar2002Mar2001Mar2000
Operational & Financial Ratios
   Earnings Per Share (Rs)0.00-0.01-0.80-2.53-1.00
   CEPS(Rs)0.00-0.01-0.56-2.23-0.68
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)9.739.733.083.706.06
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)3.10-60.95-2701.87-381.58
   EBIT Margin(%)-2.84-75.84-2965.18-568.68
   Pre Tax Margin(%)-2.84-92.05-3149.32-668.91
   PAT Margin (%)-2.84-92.05-3149.32-668.91
   Cash Profit Margin (%)3.10-65.17-2766.38-451.90
Performance Ratios
   ROA(%)-0.03-0.30-13.40-32.58-10.59
   ROE(%)-0.03-0.30-23.53-51.92-15.48
   ROCE(%)-0.03-0.30-14.17-37.22-10.41
   Asset Turnover(x)0.010.000.150.010.02
   Sales/Fixed Asset(x)0.730.000.160.010.02
   Working Capital/Sales(x)6.160.004.970.130.11
Efficiency Ratios
   Fixed Capital/Sales(x)1.366.2280.4748.78
   Receivable days94.02137.1218.31348.05
   Inventory Days3.750.005090.633320.27
   Payable days64.50239.98169.630.00
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.00-64.820.00-0.45-5.02
   Price/Book(x)0.000.060.000.270.56
   Yield(%)0.000.000.00
   EV/Net Sales(x)92.1512.5926.9631.41
   EV/Core EBITDA(x)2972.56-68.41-25.72-1.04-8.93
   EV/EBIT(x)-3248.67-38.84-16.60-0.91-5.52
   EV/CE(x)1.030.062.080.330.53
   M Cap / Sales0.000.0012.4222.69
Growth Ratio
   Net Sales Growth(%)-100.00976.56-46.29-92.40
   Core EBITDA Growth(%)139.7743.0479.59-294.3921.77
   EBIT Growth(%)79.3435.2372.46-180.0611.34
   PAT Growth(%)79.3446.6468.53-152.8815.28
   EPS Growth(%)79.3498.1368.53-152.8815.28
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.320.400.26
   Current Ratio(x)1.961.441.271.834.51
   Quick Ratio(x)1.901.441.270.651.10
   Interest Cover(x)-4.68-16.10-5.67
   Total Debt/Mcap(x)0.061.500.46

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.